T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Kai Rejeski(Memorial Sloan Kettering Cancer Center), Roni Shouval(Memorial Sloan Kettering Cancer Center), Tsila Zuckerman(Johannes Gutenberg University Mainz), Marina Gómez-Llobell(Universidad Complutense de Madrid), Avichai Shimoni, Ronit Marcus(Sheba Medical Center), Frederick L. Locke(University of Chicago), Gunjan L. Shah(Cornell University), Monica Nair(National Institutes of Health), Marcela V. Maus(Broad Institute), Nirali N. Shah(National Institutes of Health), Ofrat Beyar‐Katz(Rambam Health Care Campus), Jaime Sanz(Memorial Sloan Kettering Cancer Center), Veit Bücklein(Ludwig-Maximilians-Universität München), Netta Glaubach(Rambam Health Care Campus), Michael Scordo(Cornell University), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Abraham Avigdor(Sheba Medical Center), Jonathan H. Esensten(University of California, San Francisco), Sandeep Raj, Sham Mailankody(Memorial Sloan Kettering Cancer Center), Sridevi Rajeeve(Memorial Sloan Kettering Cancer Center), Orit Itzhaki(Sheba Medical Center), Sigrun Einarsdottir(Memorial Sloan Kettering Cancer Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Gilles Salles(Université Claude Bernard Lyon 1), Marcelo C. Pasquini(Medical College of Wisconsin), Yannis K. Valtis(Brigham and Women's Hospital), Tobias Tix(LMU Klinikum), Teng Fei(Wuhan University), Jae H. Park, Noa Golan-Accav(Tel Aviv University), Iris Halamis(Rambam Health Care Campus), Hamza Hashmi(Medical University of South Carolina), Ori Ben Valid(Tel Aviv University), Saad Z. Usmani(University of Arkansas for Medical Sciences)
Blood
April 21, 2025
Cited by 31


Related Papers